Lung cancer -- Lung cancer News
Lung cancer News Mon 2 Jun 2008
Tarceva(R) Delivers Benefits Across Broad Range of NSCLC Patients - Confirmed by New Data
CHICAGO, IIL 2 Jun PRNewswire AsiaNet/InfoQuest Tarceva Extends Length and Quality of Life in Largest Non Small Cell Lung Cancer (NSCLC) Phase IV Study Ever Conducted New data presented at ASCO 2008 from TRUST(1), the largest non small cell lung cancer (NSCLC) Phase IV trial ever conducted, show that a broad range ofread more
Lung cancer News Thu 29 May 2008
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
INDIANAPOLIS, IN. 29 May PRNewswire AsiaNet/InfoQuest Patients with Adenocarcinoma or Large Cell Carcinoma Histologies Achieved Improvement in Overall Survival when Treated with ALIMTA based Regimen The type of non small cell lung cancer (NSCLC) patients have may now influence their treatment regimen and, in turn,read more
Lung cancer News Fri 16 May 2008
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
INDIANAPOLIS, IN. 16 May PRNewswire AsiaNet/InfoQuest Lung cancer patients whose histology is factored into treatment decisions may fare better as a result, according to data from a pivotal non small cell lung cancer (NSCLC) clinical trial. Data from the trial, which involved Eli Lilly and Company's ALIMTA(R)read more
Lung cancer News Fri 2 May 2008
Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008
INDIANAPOLIS 2 May PRNewswire AsiaNet/InfoQuest ALIMTA Lung Cancer Study Highlighting Key Histology Findings to Be Included in May 15 ASCO Live, Online Presscast Eli Lilly and Company will unveil data from more than 50 studies at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago,read more
Lung cancer News Thu 29 Nov 2007
Lung Cancer Patients Face a Void of Emotional Support
The International Psycho Oncology Society Introduce a New Global Quality of Life Initiative With the Support of Roche Concerning results from a Europe wide survey released today during Lung Cancer Awareness Month reveal that one in three lung cancer patients feel that they are not receiving the emotional support theyread more
Lung cancer News Thu 6 Sep 2007
Boehringer Ingelheim to Initiate First Phase III Pivotal Study for New Oncology Compound BIBW 2992*
New data on BIBW 2992*, a potent, irreversible, second generation oral signal transduction inhibitor provides glimpse of next chapter in lung cancer care Boehringer Ingelheim announced today from the 12th World Conference on Lung Cancer (WCLC) that the company plans to commence Phase III pivotal trials in lung cancerread more
Lung cancer News Wed 5 Sep 2007
Roche's Tarceva(R) Delivers Longer Life for Lung Cancer Patients
Patients worldwide with advanced lung cancer can expect longer survival according to new data from the TRUST study presented at the 12th World Conference on Lung Cancer (WCLC) in Seoul, Korea. These new worldwide observations show that patients suffering from non small cell lung cancer (NSCLC) and treated with Tarcevaread more
Lung cancer News Tue 4 Sep 2007
Media Invitation: Are You Ready for the Next Chapter in Lung Cancer Care?
Ready for fresh perspectives on mutational research, future treatment prospects in non small cell lung cancer (NSCLC) and a milestone announcement from Boehringer Ingelheim? Learn more at the upcoming international media webcast, 'The second generation revealing the next chapter in the evolution of lung cancer care'read more
Data Affirm Benefit of ALIMTA(R) (pemetrexed for injection) for Patients with Non-Small Cell Lung Cancer
The clinical benefit of ALIMTA(R) (pemetrexed for injection) continues to be validated across patient populations, as demonstrated in two studies conducted in Asia. The data presented today at the 12th World Conference on Lung Cancer provide further support of the efficacy of Eli Lilly and Company's ALIMTA in treatingread more
Lung cancer News Mon 27 Aug 2007
Avastin Approved in Europe for First-line Treatment of Patients with Advanced Lung Cancer
First Medicine Shown to Extend Survival Beyond One Year in Previously Untreated Lung Cancer Patients Avastin (bevacizumab), Roche's innovative anti cancer drug, was approved today in Europe for the first line treatment of patients with advanced non small cell lung cancer (NSCLC), in combination with platinum basedread more
Lung cancer News Fri 24 Aug 2007
Media Invitation: Are You Ready for the Next Chapter in Lung Cancer Care?
Ready for Fresh Perspectives on Mutational Research, Future Treatment Prospects in Non Small Cell Lung Cancer (NSCLC) and a Milestone Announcement From Boehringer Ingelheim? Learn more at the upcoming international media webcast, 'The second generation revealing the next chapter in the evolution of lung cancer care'read more
Lung cancer News Mon 23 Jul 2007
Avastin(R) Receives Positive Opinion in Europe for First-Line Treatment of Patients with Advanced Lung Cancer
First Medicine Shown to Extend Survival of Previously Untreated Patients Beyond One Year Roche announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for the first line use of Avastin in the treatment of the most common form of lung cancer, inread more
Lung cancer News Fri 15 Jun 2007
AsiaNet Daily Summary - Press Releases for Friday, June 15
EWING INVESTS... DALLAS, TX,: Ewing Management Group (EMG) announced Friday it completed US$100 million of investments in two Chinese companies in the first half of 2007. http://www.emglp.com LUNG CANCER... LONDON: The Global Lung Cancer Coalition is organising the 2nd Annual Lung Cancer Journalism Awards Competition.read more
The Global Lung Cancer Coalition Presents the 2nd Annual Lung Cancer Journalism Awards Competition
The Lung Cancer Journalism Awards' mission: to raise global awareness of the leading cause of cancer related deaths worldwide. Winners receive: Global showcase recognising their prize winning work EUR 7,000 research grant Enter to win 3 different categories: Best Medical Article Best Consumer Article Best Broadcastread more
Lung cancer News Mon 4 Jun 2007
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
Study Highlights Quality of Life Data ALIMTA(R) (pemetrexed for injection) showed additional utility in the treatment of the most diagnosed type of cancer(i), according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). Results from a Phase III study suggest that aread more
Avastin(R) Significantly Prolongs Progression Free Survival in Patients With Advanced Lung Cancer
Only First line Treatment to Demonstrate Extended Survival in Over a Decade Avastin (bevacizumab), significantly improves the time patients with advanced non small cell lung cancer (NSCLC) live without their disease advancing ("progression free survival") when added to cisplatin/gemcitabine chemotherapy, compared withread more
Lung cancer News Tue 27 Feb 2007
Fourth Phase III Study of Vandetanib (ZACTIMA(TM), ZD6474) in Patients With Advanced Lung Cancer
A Phase III international, parallel group, randomised, double blind study of vandetanib in combination with pemetrexed for advanced non small cell lung cancer (NSCLC) after failure of first line anti cancer therapy AstraZeneca today announced that a new Phase III study of novel once daily oral anti cancer drug,read more
Lung cancer News Thu 14 Dec 2006
Landmark Study of Avastin in Lung Cancer Published Today in New England Journal of Medicine
Avastin is First Medicine to Extend Survival Beyond One Year in Patients With Previously Untreated Non Small Cell Lung Cancer Avastin is the first medicine proven to help previously untreated patients suffering from the most common form of lung cancer to live longer than a year, according to a landmark US studyread more
Lung cancer News Thu 30 Nov 2006
2007 Lung Cancer Journalism Awards
Lung cancer News Wed 15 Nov 2006
Awards Breathe Life into Lung Cancer Reporting
Winners of First International Journalism Awards for Reporting on Lung Cancer announced today A selection of journalists were officially recognised today, during Lung Cancer Awareness Month, for their role in helping to elevate the often neglected profile of lung cancer, the leading cause of cancer related deathsread more
Lung cancer News Tue 31 Oct 2006
New Survey Reveals Startling Ignorance About Europe's Number One Cancer Killer - Lung Cancer
Seventy percent of European patients battling lung cancer had never regarded the disease as a threat prior to learning of their condition, according to results from a new pan European public and patient survey announced on the eve of Lung Cancer Awareness Month. This ignorance about lung cancer is also indicative of aread more
RSS Feed